Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 3 3Phase 1/2 3

Status

Terminated 2Completed 2Suspended 1

Sponsor Class

INDUSTRY 5NIH 1

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 3

Conditions

Neoplasms 1522Carcinoma, Non-Small-Cell Lung 758Breast Neoplasms 572Neoplasm Metastasis 531Colorectal Neoplasms 448Melanoma 391Leukemia, Myeloid, Acute 372Multiple Myeloma 364Ovarian Neoplasms 354Recurrence 336Lymphoma 334Advanced Solid Tumors 325Lymphoma, Non-Hodgkin 315Prostatic Neoplasms 300Pancreatic Neoplasms 285Advanced Solid Tumor 240Stomach Neoplasms 233Carcinoma, Renal Cell 226Squamous Cell Carcinoma of Head and Neck 211Lung Neoplasms 210Solid Tumor 204Leukemia, Lymphocytic, Chronic, B-Cell 198Triple Negative Breast Neoplasms 185Solid Tumors 183Carcinoma, Hepatocellular 165Hematologic Neoplasms 155Head and Neck Neoplasms 153Lymphoma, Large B-Cell, Diffuse 148Lymphoma, Follicular 146Glioblastoma 145

Interventions

AZD3514 15'-ACCaagtttcttcAGC-3' 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × INDUSTRY × Bulbo-Spinal Atrophy, X-Linked × Clear all
NCT05241613 2025-02-13

A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Accutar Biotechnology Inc

Phase 1 Terminated
28 enrolled

Bulbo-Spinal Atrophy, X-Linked

NCT05673109 2024-01-25

A Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate Cancer

Accutar Biotechnology Inc

Phase 1 Terminated
8 enrolled

Bulbo-Spinal Atrophy, X-Linked

NCT02162836 2020-04-27

A Safety Study of JNJ-56021927 in Participants With Metastatic Castration-Resistant Prostate Cancer

Janssen Pharmaceutical K.K.

Phase 1 Completed
6 enrolled
Genitourinary

Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked, Prostatic Neoplasms, Castration-Resistant

NCT01351688 2013-07-03

An Open Label Prostate Cancer Study in Japanese Patients

AstraZeneca

Phase 1 Completed
13 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

NCT01337518 2012-12-18

A Phase 1a/1b Study to Evaluate the Safety of EZN-4176, in Adult Patients With Castration-Resistant Prostate Cancer

Enzon Pharmaceuticals, Inc.

Phase 1 Suspended
150 enrolled
Genitourinary

Adenocarcinoma, Neoplasm Metastasis, Prostatic Neoplasms, Bulbo-Spinal Atrophy, X-Linked

Data powered by HemOnc (CC BY 4.0) Colophon âš¡